Literature DB >> 10914676

Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.

F Ishibashi1, H Nunoi, F Endo, I Matsuda, S Kanegasaki.   

Abstract

Chronic granulomatous disease (CGD) is a group of inherited disorders of host defense caused by a mutation in any of the four components of phagocyte NADPH oxidase, namely gp91-, p22-, p47-, and p67-phox. We have made a precise statistical analysis of 229 registered patients from 195 families in Japan and mutation analysis of 28 and 5 independent patients, respectively, with gp91- and p22-phox deficiency. The gp91- and p22-phox proteins form the membrane cytochrome b558, which plays important roles in the assembly of the active oxidase and electron-transfer reaction, and the lesions in either subunit account for more than 80% of cases. The ratio of male to female patients was 6.6/1, the incidence was calculated to be about 1 out of 220,000 birth, and the life expectancy of the patients born in the 1970s was estimated to be 25-30 years old. For the X-linked gp91-phox deficiency, we found five missense and nine nonsense mutations, seven deletions, three insertions, and four splice site mutations, which included the following novel mutations: four missense, five nonsense, six deletions, one insertion, and two splice site abnormalities. With regard to p22-phox deficiency, two homozygous nonsense mutations and one homozygous deletion, a missense mutation together with a splice site mutation, and two different missense mutations were found. These mutations have not been reported before. Based on the present and reported data from Japan, we discuss the molecular defects of the disease and the difference in statistics between western countries and Japan.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914676     DOI: 10.1007/s004390000288

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

Review 1.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

2.  Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia.

Authors:  R El Kares; M R Barbouche; H Elloumi-Zghal; M Bejaoui; J Chemli; F Mellouli; N Tebib; M S Abdelmoula; S Boukthir; Z Fitouri; S M'Rad; K Bouslama; H Touiri; S Abdelhak; M K Dellagi
Journal:  J Hum Genet       Date:  2006-08-26       Impact factor: 3.172

3.  Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.

Authors:  Manasi Kulkarni; Gouri Hule; Martin de Boer; Karin van Leeuwen; Priyanka Kambli; Jahnavi Aluri; Maya Gupta; Aparna Dalvi; Snehal Mhatre; Prasad Taur; Mukesh Desai; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2018-11-23       Impact factor: 8.317

4.  Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease.

Authors:  Hideko Kajiwara; Mitsumasa Saito; Shouichi Ohga; Takeshi Uenotsuchi; Shin-ichi Yoshida
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  Enhanced generation of reactive oxygen species by interferon-γ may have contributed to successful treatment of invasive pulmonary aspergillosis in a patient with chronic granulomatous disease.

Authors:  Kouhei Yamashita; Takashi Miyoshi; Yasuyuki Arai; Kiyomi Mizugishi; Akifumi Takaori-Kondo; Takehiko Ueyama
Journal:  Int J Hematol       Date:  2013-03-24       Impact factor: 2.490

6.  Complex management of a patient with a contiguous Xp11.4 gene deletion involving ornithine transcarbamylase: a role for detailed molecular analysis in complex presentations of classical diseases.

Authors:  Matthew A Deardorff; Himabindu Gaddipati; Paige Kaplan; Pedro A Sanchez-Lara; Neal Sondheimer; Nancy B Spinner; Hakon Hakonarson; Can Ficicioglu; Jaya Ganesh; Thomas Markello; Brett Loechelt; Dina J Zand; Marc Yudkoff; Uta Lichter-Konecki
Journal:  Mol Genet Metab       Date:  2008-06-03       Impact factor: 4.797

7.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

8.  Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease.

Authors:  Taizo Wada; Masahiro Muraoka; Tomoko Toma; Tsuyoshi Imai; Tomonari Shigemura; Kazunaga Agematsu; Kohei Haraguchi; Hiroyuki Moriuchi; Tsutomu Oh-Ishi; Toshiyuki Kitoh; Osamu Ohara; Tomohiro Morio; Akihiro Yachie
Journal:  J Clin Immunol       Date:  2013-01-10       Impact factor: 8.317

Review 9.  Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Jacinta Bustamante; Caroline Kannengiesser; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Baruch Wolach; Joachim Roesler; Harry L Malech; Steven M Holland; John I Gallin; Marie-José Stasia
Journal:  Blood Cells Mol Dis       Date:  2010-02-18       Impact factor: 3.039

10.  Genetic analysis of 10 unrelated Korean families with p22-phox-deficient chronic granulomatous disease: an unusually identical mutation of the CYBA gene on Jeju Island, Korea.

Authors:  Young Mee Kim; Ji Eun Park; Jin Young Kim; Hee Kyung Lim; Jae Kook Nam; Moonjae Cho; Kyung-Sue Shin
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.